Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

01 déc. 2025 09h56 HE | Source: Research and Markets

Gene Editing Technology Trends and Forecast Report 2025: A $10+ Billion Market by 2030, Driven by Technological Advancements, Personalized Medicine Demand, and Rising Genetic & Chronic Disease Burden

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Gene Editing Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
28 nov. 2025 07h45 HE | Source: Research and Markets

Huntington's Disease Market Opportunity Assessment and Forecast Report

Dublin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The "Huntington's Disease: Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering.This report covers the 7MM and...
26 nov. 2025 07h28 HE | Source: Research and Markets

Gene Therapy Collaboration and Licensing Agreements Trends Analysis Report 2025 with Directory of 787 Deals Signed Since 2016 by Company A-Z, Therapy Focus and Technology Type

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...
24 nov. 2025 08h55 HE | Source: SNS Insider pvt ltd

Viral Vector Manufacturing Market to Surpass USD 10.65 Billion by 2033, Driven by Surging Gene Therapy Pipelines and Advanced Vector Engineering | SNS Insider

Austin, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Viral Vector Manufacturing Market Size & Growth Analysis: According to a comprehensive report by SNS Insider, the Viral Vector Manufacturing Market...
21 nov. 2025 07h07 HE | Source: Research and Markets

U.S. Cell and Gene Therapy CDMO Market Trends Analysis Report 2025-2033: Gene & CAR-T Therapy Boom Drives Demand for CDMO Partnerships and Specialized Manufacturing Capacity

Dublin, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The "U.S. Cell and Gene Therapy CDMO Market Size, Share & Trends Analysis Report by Phase (Pre-clinical, Clinical), Product (Gene Therapy, Cell Therapy,...
20 nov. 2025 08h00 HE | Source: Medidata Solutions, Inc.

Caidya Reimagines Next Generation Clinical Trial Innovation and Study Delivery with Medidata AI-Powered Experiences

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that Caidya, a leading...
20 nov. 2025 07h02 HE | Source: Ocugen

Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference

MALVERN, Pa., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that...
19 nov. 2025 13h00 HE | Source: DelveInsight Business Research LLP

Gene Therapy for Ocular Rare Disease Market to Exhibit Phenomenal Growth During the Forecast Period (2025–2034) Due to Expanding Pipeline and Clinical Trial Activities | DelveInsight

New York, USA, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Gene Therapy for Ocular Rare Disease Market to Exhibit Phenomenal Growth During the Forecast Period (2025–2034) Due to Expanding Pipeline and...
17 nov. 2025 08h00 HE | Source: Calidi Biotherapeutics, Inc

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of...
14 nov. 2025 07h00 HE | Source: Coave Therapeutics

Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for suprachoroidal delivery

Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for suprachoroidal delivery CoTx-101 represents a potential breakthrough for...

Page suivante